NXGL
NEXGEL, Inc. NASDAQ Listed Dec 22, 2021$0.50
-4.06%
vs $0.52
Mkt Cap $3.9M
52w Low $0.50
0.0% of range
52w High $2.78
50d MA $0.58
200d MA $1.38
P/E (TTM)
-1.3x
EV/EBITDA
—
P/B
0.8x
Debt/Equity
0.7x
ROE
-67.3%
P/FCF
-2.9x
RSI (14)
39.70
ATR (14)
$0.07
Beta
0.85
50d MA
$0.58
200d MA
$1.38
Avg Volume
384.7K
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
2150 Cabot Boulevard West · Langhorne, PA 19047 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | BMO | -0.07 | -0.11 | -57.1% | 0.58 | +0.2% | -8.1% | +1.7% | -5.9% | +0.2% | +20.1% | — |
| Mar 31, 2026 | BMO | -0.09 | -0.11 | -22.2% | 0.63 | -0.5% | -1.3% | -5.4% | +10.0% | -6.0% | +4.4% | — |
| Nov 11, 2025 | BMO | -0.09 | -0.08 | +11.1% | 2.28 | +0.0% | -11.4% | -5.9% | +0.5% | -3.7% | -3.3% | — |
| Aug 12, 2025 | BMO | -0.01 | -0.09 | -800.0% | 2.71 | -11.1% | -11.4% | -7.1% | +9.0% | -4.9% | +3.5% | — |
| May 13, 2025 | BMO | -0.10 | -0.09 | +10.0% | 2.76 | -0.4% | -9.1% | -5.6% | +1.7% | -0.8% | -2.1% | — |
| Mar 24, 2025 | BMO | -0.10 | -0.08 | +20.0% | 3.09 | -5.8% | -1.9% | -2.0% | +2.7% | -5.6% | +3.5% | — |
| Nov 13, 2024 | BMO | -0.10 | -0.11 | -10.0% | 3.29 | -3.3% | -3.3% | -3.8% | +1.3% | +5.2% | +1.2% | — |
| Aug 19, 2024 | BMO | -0.14 | -0.14 | +0.0% | 2.53 | +2.0% | +4.0% | +0.4% | +4.9% | -6.1% | +7.7% | — |
| May 13, 2024 | BMO | -0.18 | -0.14 | +22.2% | 2.25 | +4.4% | -2.2% | +1.4% | +2.7% | +3.5% | -2.5% | — |
| Apr 1, 2024 | BMO | -0.11 | -0.19 | -72.7% | 2.24 | -1.3% | +6.2% | -2.5% | -1.7% | -5.7% | +3.3% | — |
| Nov 13, 2023 | BMO | -0.12 | -0.10 | +16.7% | 1.76 | +7.4% | +1.7% | +0.0% | -1.3% | +0.8% | +3.4% | — |
| Aug 14, 2023 | BMO | -0.13 | -0.12 | +7.7% | 1.86 | +0.0% | -5.9% | +15.1% | +1.7% | -1.5% | -2.0% | — |
| May 15, 2023 | AMC | -0.14 | -0.15 | -7.1% | 1.56 | +2.6% | +0.1% | +7.4% | +0.9% | +12.3% | +4.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 | Maxim Group | Maintains | Buy → Buy | — | $0.82 | $0.84 | +2.2% | +16.2% | -13.0% | -0.5% | -0.4% | -2.3% |
| Feb 25 | Maxim Group | Maintains | Buy → Buy | — | $1.81 | $1.79 | -1.1% | +7.2% | -1.0% | -0.3% | -1.3% | -4.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 5,000 | $0.59 | $3K | 322,692 | -3.33% | -4.06% |
| Jun 18, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 6,000 | $0.59 | $4K | 327,692 | -3.33% | -4.06% |
| Jun 11, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 3,000 | $0.61 | $2K | 333,692 | -0.75% | -8.51% |
| Jun 8, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 3,000 | $0.55 | $2K | 336,692 | -2.77% | -0.75% |
| Jun 4, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 3,000 | $0.59 | $2K | 339,692 | -2.77% | -0.75% |
| Jun 1, 2026 | Levy Adam R.Dir/Off | Chief Executive Officer | Sell | 2,000 | $0.59 | $1K | 342,692 | +0.17% | -2.77% |
8-K · 7.01
! Medium
NEXGEL, Inc. -- 8-K 7.01: Regulation FD Disclosure
NexGel updated its investor presentation, likely to reflect recent business developments and improve communications with shareholders regarding company strategy and financial performance.
Jun 17
8-K · 5.02
!!! Very High
NEXGEL, Inc. -- 8-K 5.02: Executive Change
May 12
8-K
NexGel, Inc -- 8-K Filing
NexGel received a Nasdaq compliance notice requiring the company to meet minimum bid price requirements within a specified period, potentially necessitating a reverse stock split to maintain listing eligibility.
Apr 24
8-K · 1.01
!! High
NexGel, Inc -- 8-K 1.01: License Agreement
NexGel acquired an exclusive license to commercialize Celularity's technology through an asset purchase agreement, potentially expanding its product portfolio and market reach.
Apr 21
8-K · 1.01
!! High
NexGel, Inc -- 8-K 1.01: Material Agreement
NexGel entered into a Securities Purchase Agreement, indicating the company is raising capital through equity or debt issuance, which could dilute existing shareholders but provides funds for operations or growth initiatives.
Feb 11
Institutional (13F) — Top 10
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 170,808 | $275K | Reduced | Dec 2025 |
| 2 | Jane Street Group, Llc | 29,470 | $47K | New | Dec 2025 |
| 3 | Renaissance Technologies Llc | 50,960 | $32K | Reduced | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 48,920 | $31K | New | Mar 2026 |
| 5 | Vanguard Fiduciary Trust Co | 34,040 | $22K | New | Mar 2026 |
| 6 | Flax Pond Capital, Llc | 20,000 | $13K | New | Mar 2026 |
| 7 | Hrt Financial Lp | 15,496 | $9K | New | Mar 2026 |
| 8 | Ubs Group Ag | 6,634 | $4K | Added | Mar 2026 |
| 9 | Citigroup Inc | 995 | $2K | New | Dec 2025 |
| 10 | Royal Bank Of Canada | 32 | — | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 10
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 32,216 | $37K | Feb 2026 |
| 2 | Fidelity Total Market Index Fund | 13,583 | $16K | Feb 2026 |
| 3 | Fidelity Series Total Market Index Fund | 8,676 | $10K | Feb 2026 |
| 4 | Dimensional US Core Equity 1 ETF | 3,356 | $5K | Jan 2026 |
| 5 | U.S. Social Core Equity 2 Portfolio | 1,225 | $2K | Jan 2026 |
| 6 | Dimensional U.S. Core Equity 2 ETF | 857 | $1K | Jan 2026 |
| 7 | Fidelity Nasdaq Composite Index Fund | 546 | $628 | Feb 2026 |
| 8 | U.S. MICRO CAP PORTFOLIO | 198 | $281 | Jan 2026 |
| 9 | U.S. SMALL CAP PORTFOLIO | 152 | $216 | Jan 2026 |
| 10 | Dimensional U.S. Small Cap ETF | 144 | $204 | Jan 2026 |
Valuation
Market Cap
$3.9M
Enterprise Value
$4.1M
P/E (TTM)
-1.26x
Forward P/E
—
PEG Ratio
0.18x
P/B
0.80x
P/S
0.35x
P/FCF
-2.85x
EV/EBITDA
—
Shares Out
7.9M
Financials (TTM)
Revenue
$11.3M
Net Income
-$3.2M
EBITDA
-$2.2M
Free Cash Flow
-$1.4M
Op Cash Flow
-$1.3M
EPS Basic
$-0.38
EPS Diluted
$-0.40
EPS Forward
$-0.06
Gross Margin
38.9%
Op Margin
-31.4%
Net Margin
-28.5%
Balance Sheet
Total Assets
$10.5M
Total Liab.
$5.6M
Total Equity
$4.9M
Cash
$317K
LT Debt
$489K
Book Value/Sh
$0.62
Debt/Equity
0.69x
Current Ratio
1.47
Quick Ratio
0.75
Returns & Growth
ROE
-67.3%
ROA
-28.7%
ROIC
-42.0%
Rev Growth YoY
+31.5%
EPS Growth YoY
+24.0%
Price Returns
2W
-5.2%
1M
-13.0%
3M
-14.0%
6M
-66.7%
12M
-79.8%
Technicals
52W High
$2.78
52W Low
$0.50
50d MA
$0.58
200d MA
$1.38
RSI (14)
39.70
ATR (14)
$0.07
Beta
0.85
Avg Volume
385K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 4:33pm
· Source: financialmodelingprep.com